Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) Study.
Gerrit Maximilian GrosseChristian WeimarNils KuklikAnika HüsingAndreas StangMarcus BrinkmannChristoph C EschenfelderHans-Christoph Dienernull nullPublished in: European stroke journal (2021)
PRODAST will provide important real-world data on safety and efficacy of antithrombotic therapy after acute stroke and TIA in patients with AF.